The Cameron InstituteThe Patented Medicine Prices Review Board has seen a turbulent 30-year history, and it’s time for a review of legislation that employs ambiguous terms and standards. We need a new perspective of the health system that does not revolve around drug price and voids the concept that one can easily identify and “solve” excessive prices.
This paper details how the PMPRB works on assumptions that are no longer valid. Based on assumptions explained within, PMPRB cannot meet expectations of Canadians with minor renovation alone, and needs to be reconstructed or replaced.
